Hema Now | Episode 16
In this episode of Hema Now, Diu Nguyen joins Jonathan Sackier to discuss breakthroughs in acute myeloid leukaemia (AML) research. From RNA-binding proteins to the future of stem cell-targeted therapies, Nguyen shares the translational goals of her lab and what’s on the horizon in AML diagnosis and treatment.
Diu Nguyen
Diu Nguyen is a Lecturer and Group Leader at the Centre for Haemato-Oncology at Barts Cancer Institute, Queen Mary University of London, UK. Her lab focuses on RNA-binding proteins in acute myeloid leukaemia, aiming to develop therapies that eliminate leukaemic stem cells, whilst preserving healthy haematopoiesis.
Timestamps:
01:20 – Quickfire Insights
03:32 – AML Breakthroughs
04:47 – Leukaemia Surprise
06:42 – Alternate Pathways
07:54 – RNA Differences
12:08 – Diagnostics Future
14:03 – RBMX Spotlight
20:21 – Targeted Therapies
27:07 – Treatment Barriers
31:32 – Three Wishes
